Marshall Wace North America’s CRH CRH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$482K Sell
10,297
-59,234
-85% -$3M ﹤0.01% 1133
2021
Q2
$3.54M Buy
69,531
+21,228
+44% +$1.06M 0.01% 651
2021
Q1
$2.27M Buy
+48,303
New +$2.17M 0.01% 788
2020
Q2
– Sell
-350,033
Closed -$9.39M – 1207
2020
Q1
$9.39M Buy
+350,033
New +$12M 0.07% 228
2019
Q4
– Sell
-143,596
Closed -$4.93M – 1330
2019
Q3
$4.93M Sell
143,596
-68,064
-32% -$2.26M 0.03% 363
2019
Q2
$6.93M Buy
211,660
+211,460
+105,730% +$6.88M 0.04% 295
2019
Q1
$6K Buy
+200
New +$5.99K ﹤0.01% 1481
2018
Q3
– Sell
-139,703
Closed -$4.94M – 989
2018
Q2
$4.94M Buy
139,703
+106,779
+324% +$3.84M 0.03% 513
2018
Q1
$1.12M Sell
32,924
-162,999
-83% -$5.78M 0.01% 968
2017
Q4
$7.07M Sell
195,923
-6,840
-3% -$245K 0.04% 480
2017
Q3
$7.71M Buy
202,763
+189,324
+1,409% +$6.7M 0.05% 431
2017
Q2
$471K Buy
+13,439
New +$483K ﹤0.01% 1101

Other funds holding CRH

Marshall Wace North America's CRH Position: Q3 2021 in Review

Marshall Wace North America reduced its CRH (CRH) stake by 85% in Q3 2021, selling an estimated $3M and leaving 10,297 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Marshall Wace North America first reported a position in CRH in Q2 2017 and has held it in 12 quarters since. The position peaked at $9.39M in Q1 2020. 219 funds tracked by Wall St. Rank hold CRH as of Q3 2021.

  • Marshall Wace North America held 10,297 shares of CRH worth $482K as of Q3 2021.
  • Marshall Wace North America sold 59,234 CRH shares in Q3 2021, an estimated $3M.
  • CRH made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1133 holding.
  • Marshall Wace North America first reported a position in CRH in Q2 2017 and has held it in 12 quarters since.
  • Marshall Wace North America's CRH position peaked at $9.39M in Q1 2020.
  • 219 funds tracked by Wall St. Rank held CRH as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.